Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

The goal of this clinical trial is to learn if OPB-201 is safe in recurrent endometrial and platinum resistant ovarian cancer participants and also to find the optimal dose of OPB-201. Participants will have their own T cells modified in a laboratory and given back to them as OPB-201 in this one-time treatment. Participants will be in the hospital when they receive OPB-201 and then be checked at the clinical site frequently for the first few months.

Participants needed: 30
Trial details
Phase: Phase 1Age: 18+Biological sex: FemaleType: InterventionalSponsor: Outpace Bio, Inc.Updated: Jun 24, 2026
Eligibility criteria

Age ≥ 18 years of age at the time of signing the informed consent form. [+9]

Women of child-bearing potential who are pregnant or breastfeeding. [+9]

Read more
Status: Recruiting

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

The goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and also to find the optimal dose of OPB-101. Participants will have their own T cells modified in a laboratory and given back to them as OPB-101 in this one-time treatment. Participants will be in the hospital when they receive OPB-101 and then be checked at the clinical site frequently for the first few months.

Participants needed: 30
Trial details
Phase: Phase 1Age: 18+Biological sex: FemaleType: InterventionalSponsor: Outpace Bio, Inc.Updated: Dec 18, 2025Locations: 4
Eligibility criteria

Age ≥ 18 years of age at the time of signing the informed consent form. [+16]

Women of child-bearing potential who are pregnant or breastfeeding. [+21]

Read more